Related Experiment Video
Updated: Jul 26, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Adoptive immunotherapy for Hodgkin's lymphoma
Alana A Kennedy-Nasser1, Catherine M Bollard, Cliona M Rooney
1Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, Texas 77030, USA.
International Journal of Hematology
|June 22, 2006
Summary
Adoptive T-cell therapy shows promise for refractory Hodgkin
Area of Science:
- Immunology and Cancer Therapy
Background:
- Adoptive T-cell therapy is a potential treatment for refractory or relapsed Hodgkin's lymphoma.
- Hodgkin's lymphoma employs immune evasion mechanisms that limit immunotherapy effectiveness.
Purpose of the Study:
- To explore strategies for overcoming immune evasion in Hodgkin's lymphoma.
- To discuss the potential of Epstein-Barr virus-specific cytotoxic T-lymphocytes and cytokine roles in immunotherapy.
Main Methods:
- Review of current research on adoptive T-cell therapy for Hodgkin's lymphoma.
- Analysis of tumor immune evasion tactics employed by Hodgkin's lymphoma.
- Discussion of Epstein-Barr virus-specific T-cells and cytokine-based strategies.
Main Results:
- Hodgkin's lymphoma exhibits significant immune evasion capabilities.
- Epstein-Barr virus-specific cytotoxic T-lymphocytes offer a targeted approach.
- Cytokines play a crucial role in modulating the immune response against lymphoma.
Conclusions:
- Overcoming immune evasion is critical for successful adoptive T-cell therapy in Hodgkin's lymphoma.
- Targeting Epstein-Barr virus and utilizing cytokine therapies are promising strategies.
More Related Videos
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.